Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs' cost ...
"Platforms often promote misinformation or oversimplified solutions," one expert told Newsweek about the findings.
However, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, warned that weight loss jabs “are not a ...
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from ...
Postpartum weight loss can feel impossible at times, especially if the weight isn’t coming off as quickly as you expected.
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
The new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that ...
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...
The veteran journalist, who celebrates his 65th birthday this week, first shared his weight loss secret back in 2021 when he ...
Those treated with tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist, lost on ...